Skip to content

FUTURE 2.0

Advanced Fetal MRI techniques: assessment of fetal cardiovascular anatomy disturbances in children with congenital heart disease - Future 2.0

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56891
Enrollment
159
Registered
2024-02-19
Start date
2025-01-27
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex congenital heart disease Congenital heart disease

Interventions

Fetal CMR

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Antenatal diagnosis of significant aortic and/or pulmonary CHD, defined as requiring intervention within the first year of postnatal life. Informed consent provided by both parents. Gestational age >24 weeks. The optimal gestational age for fetal CMR currently lies between 30-34 weeks.

Exclusion criteria

Exclusion criteria: Maternal age <16 years. Inability to correctly inform parents about study due to language barrier or other factors. Contraindication to MRI (see Radiology department checklist).

Design outcomes

Primary

MeasureTime frame
To test feasibility of fetal CMR on the three available MRI vendors (Philips, Siemens, General Electric) in all academic centers in The Netherlands.

Secondary

MeasureTime frame
To assess diagnostic capacity of fetal CMR and the additive value to fetal echocardiography (at gestational age 20-24 weeks and 30-34 weeks) for correct antenatal diagnosis of significant aortic and/or pulmonary CHD (correct CHD diagnosis based on postnatal findings).

Countries

Netherlands

Contacts

Public ContactR de Lange

Universitair Medisch Centrum Utrecht

kinderhartcentrum@umcutrecht.nl030-2504703

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026